Docosahexaenoic acid, protectin synthesis: Relevance against atherothrombogenesis

Proceedings of the Nutrition Society

Volumn 73, Issue 2, 2014, Pages 186-189

  Lagarde, Michel ^a   Liu, Miao ^a   Véricel, Evelyne ^a   Calzada, Catherine ^a   Chen, Ping ^a   Driss, Fathi ^b   Guichardant, Michel ^a  

^a UNIVERSITÉ DE LYON   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

Blood platelets; Cyclooxygenases; Leucocytes; Lipoxygenases

Indexed keywords

ALPHA TOCOPHEROL; ARACHIDONIC ACID; CD59 ANTIGEN; CHOLESTEROL ESTER; DOCOSAHEXAENOIC ACID; DOCOSAPENTAENOIC ACID; ETHANOLAMINE; GLUTATHIONE PEROXIDASE; HYDROPEROXIDE; ISOPROSTANE DERIVATIVE; LIPOXYGENASE; LOW DENSITY LIPOPROTEIN; MALONALDEHYDE; PHOSPHOLIPID; PLASMALOGEN; REACTIVE OXYGEN METABOLITE; THROMBOXANE; THROMBOXANE A2; THROMBOXANE SYNTHASE; ANTIOXIDANT; FAT INTAKE; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ANTIOXIDANT ACTIVITY; ATHEROSCLEROSIS; BLOOD CLOTTING; CARDIOVASCULAR RISK; CONFERENCE PAPER; DIET SUPPLEMENTATION; EX VIVO STUDY; FATTY ACID METABOLISM; HUMAN; IN VITRO STUDY; LEUKOCYTE; NONHUMAN; OXIDATIVE STRESS; OXYGENATION; THROMBOCYTE; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION; THROMBOCYTE FUNCTION; THROMBOSIS; BIOSYNTHESIS; BLOOD; DIET; DRUG EFFECTS; FAT INTAKE; METABOLISM; PHARMACOLOGY; THERAPEUTIC USE;

ANTIGENS, CD59; ANTIOXIDANTS; ATHEROSCLEROSIS; BLOOD PLATELETS; CHOLESTEROL, LDL; DIET; DIETARY FATS; DOCOSAHEXAENOIC ACIDS; HUMANS; LEUKOCYTES; LIPOXYGENASES; THROMBOSIS;

EID: 84898489457     PISSN: 00296651     EISSN: 14752719     Source Type: Journal    
DOI: 10.1017/S0029665113003704     Document Type: Conference Paper

References (31)

1. Ackman RG (1989) Nutritional composition of fats in seafoods. Prog Food Nutr Sci 13, 161-289
2. Bazan NG, Gordon WC & Rodriguez de Turco EB (1992) Docosahexaenoic acid uptake and metabolism in photoreceptors: Retinal conservation by an efficient retinal pigment epithelial cell-mediated recycling process. Adv Exp Med Biol 318, 295-306
3. Leaf A & Kang JX (1998) Omega 3 fatty acids and cardiovascular disease. World Rev Nutr Diet 83, 24-37
4. Weaver BJ & Holub BJ (1988) Health effects and metabolism of dietary eicosapentaenoic acid. Prog Food Nutr Sci 12, 111-150
5. Dyerberg J & Jørgensen KA (1982) Marine oils and thrombogenesis. Prog Lipid Res 21, 255-269
6. Joensen AM, Schmidt EB, Dethlefsen C, et al. (2010) Dietary intake of total marine n-3 polyunsaturated fatty acids, eicosapentaenoic acid, docosahexaenoic acid and docosapentaenoic acid and the risk of acute coronary syndrome-A cohort study. Br J Nutr 103, 602-607
7. Mozaffarian D (2005) Does alpha-linolenic acid intake reduce the risk of coronary heart disease? A review of the evidence. Altern Ther Health Med 11, 24-30
8. Ariel A & Serhan CN (2007) Resolvins and protectins in the termination program of acute inflammation. Trends Immunol 28, 176-183
9. Schwab JM, Chiang N, Arita M, et al. (2007) Resolvin E1 and protectin D1 activate inflammation-resolution programmes. Nature 447, 869-874
10. Serhan CN, Yang R, Martinod K, et al. (2009) Maresins: Novel macrophage mediators with potent antiinflammatory and proresolving actions. J Exp Med 206, 15-23
11. Aveldaño MI & Sprecher H (1983) Synthesis of hydroxy fatty acids from 4, 7, 10, 13, 16, 19-[1-14C] docosahexaenoic acid by human platelets. J Biol Chem 258, 9339-9343
12. Croset M, Sala A, Folco G, et al. (1988) Inhibition by lipoxygenase products of TXA2-like responses of platelets and vascular smooth muscle 14-Hydroxy from 22: 6n-3 is more potent than 12-HETE. Biochem Pharmacol 37, 1275-1280
13. Rizos EC, Ntzani EE, Bika E, et al. (2012) Association between omega-3 fatty acid supplementation and risk of major cardiovascular disease events: A systematic review and meta-Analysis. JAMA 308, 1024-1033
14. Kromhout D (2012) Omega-3 fatty acids and coronary heart disease. The final verdict? Curr Opin Lipido 23, 554-559
15. Véricel E, Croset M, Sedivy P, et al. (1988) Platelets and aging. I-Aggregation, arachidonate metabolism and antioxidant status. Thromb Res 49, 331-342
16. Véricel E, Calzada C, Chapuy P, et al. (1999) The influence of low intake of n-3 fatty acids on platelets in elderly people. Atherosclerosis 147, 187-192
17. Guillot N, Caillet E, Laville M, et al. (2009) Increasing intakes of the long-chain omega-3 docosahexaenoic acid: Effects on platelet functions and redox status in healthy men. FASEB J 23, 2909-2916
18. Calzada C, Colas R, Guillot N, et al. (2010) Subgram daily supplementation with docosahexaenoic acid protects lowdensity lipoproteins from oxidation in healthy men. Atherosclerosis 208, 467-472
19. Rao GH, Radha E & White JG (1983) Effect of docosahexaenoic acid (DHA) on arachidonic acid metabolism and platelet function. Biochem Biophys Res Commun 117, 549-555
20. Serhan CN, Hong S, Gronert K, et al. (2002) Resolvins: A family of bioactive products of omega-3 fatty acid transformation circuits initiated by aspirin treatment that counter proinflammation signals. J Exp Med 196, 1025-1037
21. Sharma NP, Dong L, Yuan C, et al. (2010) Asymmetric acetylation of the cyclooxygenase-2 homodimer by aspirin and its effects on the oxygenation of arachidonic, eicosapentaenoic, and docosahexaenoic acids. Mol Pharmacol 77, 979-986
22. Lagarde M, Bernoud-Hubac N, Calzada C, et al. (2013) Lipidomics of essential fatty acids and oxygenated metabolites. Mol Nutr Food Res 57, 1347-1358
23. Mukherjee PK, Marcheselli VL, Serhan CN, et al. (2004) Neuroprotectin D1: A docosahexaenoic acid-derived docosatriene protects human retinal pigment epithelial cells from oxidative stress. Proc Natl Acad Sci U S A 101, 8491-8496
24. Marcheselli VL, Mukherjee PK, Arita M, et al. (2010) Neuroprotectin D1/protectin D1 stereoselective and specific binding with human retinal pigment epithelial cells and neutrophils. Prostaglandins Leukot Essent Fatty Acids 82, 27-34
25. Chen P, Fenet B, Michaud S, et al. (2009) Full characterization of PDX, a neuroprotectin/protectin D1 isomer, which inhibits blood platelet aggregation. FEBS Lett 583, 3478-3484
26. Chen P, Véricel E, Lagarde M, et al. (2011) Poxytrins, a class of oxygenated products from polyunsaturated fatty acids, potently inhibit blood platelet aggregation. FASEB J 25, 382-388
27. Dona M, Fredman G, Schwab JM, et al. (2008) Resolvin E1, an EPA-derived mediator in whole blood, selectively counterregulates leukocytes and platelets. Blood 112, 848-855
28. Boussetta T, Raad H, Lettéron P, et al. (2009) Punicic acid a conjugated linolenic acid inhibits TNFalpha-induced neutrophil hyperactivation and protects from experimental colon inflammation in rats. PLoS ONE 4, e6458
29. Liu M, Chen P, Véricel E, et al. (2011) Anti-Aggregatory and anti-inflammatory effects of protectin DX, a major 15-lipoxygenase product of docosahexaenoic acid. Chem Phys Lipids 164, 50S.
30. Véricel E, Polette A, Bacot S, et al. (2003) Pro-And antioxidant activities of docosahexaenoic acid on human blood platelets. J Thromb Haemost 1, 566-572
31. Strokin M, Sergeeva M & Reiser G (2003) Docosahexaenoic acid and arachidonic acid release in rat brain astrocytes is mediated by two separate isoforms of phospholipase A2 and is differently regulated by cyclic AMP and Ca2+. Br J Pharmacol 139, 1014-1022